NCT04267250View on ClinicalTrials.gov

Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 24, 2020

Primary Completion Date

November 6, 2020

Study Completion Date

November 6, 2020

Conditions
Healthy Female Volunteers
Interventions
DRUG

PF-06700841

60 mg by mouth (PO) once daily (QD).

DRUG

Ethinyl estradiol (EE) and levonorgestrel (LN)

Oral tablet containing 30 mcg EE and 150 mcg LN.

Trial Locations (2)

33126

Quotient Sciences-Miami, Miami

33134

Quotient Sciences Screening Office, Coral Gables

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04267250 - Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids | Biotech Hunter | Biotech Hunter